Skip to main content
OpenTrials
Completed

NCT Number: NCT01706744

Effect of Discharge Via an Intermediate Care Unit

The main goal is to investigate the following topics:

1. Can discharge via the Intermediate Care Unit in Stjørdal, compared to direct discharge to Verdal Municipality, be equally effective in preventing aggravation of disease and loss of function for patients over 60 years that have been hospitalized in Levanger hospital? 2. Are the cost by discharge to the Intermediate Care Unit in Stjørdal, when the hospital is not located in the same Municipality, comparable to the cost by direct discharge to the Municipality of Verdal, for patients over 60 years that have been hospitalized in Levanger hospital? 3. Which issues are considered important by patients and health personnel during discharge, arrival and follow up in the Municipality, to ensure an optimal interaction between the involved units.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patients Aged

Age range

60 year–99 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sykehuset Levanger, Levanger, Norway

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients 60 years old or older from Stjørdal- or Verdal municipality,

  • given consent,
  • admitted from their home,
  • diagnostics completed and necessary treatment started
  • the patient need not less than 3-4 days institutionalization for treatment/rehabilitation/care

Exclusion criteria

  • Patients with severe dementia
  • Patients with severe disease who cannot give consent
  • Patients with severe disease with short life expectancy (including severe cancer)

Treatment and study plan

Intermediate care unit

Other

Local health care 1

Other

Local health care 2

Other

Primary outcomes

  1. Hospital readmission

    Time frame: 30 days

    Acute admission to hospital within 30 days from previous discharge

  2. Use of local health care services

    Time frame: up to 1 year

Secondary outcomes

  1. death

    Time frame: up to 1 year

  2. hospital admission

    Time frame: up to 1 year

  3. functional assessment status

    Time frame: up to 6 months

  4. Health service cost

    Time frame: up to 1 year

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Registry information

Official study title

Can Discharge Via an Intermediate Care Unit Prevent Aggravation of Disease and Loss of Functionality, Without Increasing the Level of Cost? A Controlled Observational Study

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Oct 15, 2012
Registry last updated
Dec 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.